Unilever (UN, $55.51) Plans To Acquire GSK(GSK, $41.87 ) India Consumer Healthcare for $3.9 billion
Unilever wants to buy GlaxoSmithKline’s Indian Consumer Healthcare business.
Unilver will spend £3.1 billion ($3.9 billion) to merge its Indian unit, called Hindustan Unilever (HUL), with GSK Consumer Healthcare India. GSK accounts for more than 60% of India's health drinks market, according to consulting firm RedSeer. GSK owns India’s top nutritional malted drink brands, namely Horlicks and Boost. If the merger gets finalized, Unilever will be able to own these brands and more. Unilever also plans to acquire GSK's business in India's neighboring country Bangladesh as well as nutrition brand rights for "certain other territories" at a price of £566 million ($723 million).
The deal is awaiting approvals from the shareholders of Hindustan Unilever and GSK India, as well as from Indian regulators. It is expected to close by the end of 2019.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Advertisement
Advertisement